NeuroMetrix (NURO) - EV/EBITDA Multiple

NeuroMetrix Corporation - graphic logo of issuer NURO

NeuroMetrix, Inc. (NURO) neurostimulator assembly shops operate at constant capacity, implementing automation for quality control. The device creation model relies on a fabless approach with Asian manufacturing and US-based warehousing. Market price fluctuations on GURU.Markets show an EV/EBITDA of , while electronics manufacturing and logistics are outsourced to third-party contractors to optimize the supply of therapy systems.

NURO NeuroMetrix Corp: Enterprise Value to Operating Income Before Depreciation in the range 07/04/2022 - 11/12/2026
Manufactured products of NeuroMetrix

This ratio compares the total enterprise value, including debt load, to its operating profit before depreciation and amortization. The metric assesses cash flow generation efficiency, which is critical when implementing costly automated SMT lines and sensor calibration robotics at NeuroMetrix, Inc. (NURO). The EV/EBITDA multiple dynamics for NeuroMetrix, Inc. (NURO) allow for the determination of the asset's degree of undervaluation relative to its actual production capacities.

Competitors of NeuroMetrix, Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|Utah Medical (UTMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation KRMD|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|Company Value to EBITDA microbotmedical.com MBOT|Enterprise Value to EBITDA Ratio PDEX (Pro-Dex)|EV/EBITDA Multiple Zentek Ltd (ZTEK)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Elutia Corp ELUT|Business Value to Operating Income Before Depreciation MLSS|NXGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Retractable Technologies|Harvard Bioscience (HBIO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Femasys Inc|MHUA (Meihua Medical Technologies) - EV/EBITDA Multiple|Company Value to EBITDA Predictive Oncology Corp POAI|Enterprise Value to EBITDA Ratio CJMB (Callan JMB Inc)|Enterprise Value to Operating Income Before Depreciation Ratio ATRI